[go: up one dir, main page]

GB201911071D0 - Antibacterial activity of selected prebiotic oligosaccharides and xylitol in dermatological treatment - Google Patents

Antibacterial activity of selected prebiotic oligosaccharides and xylitol in dermatological treatment

Info

Publication number
GB201911071D0
GB201911071D0 GBGB1911071.7A GB201911071A GB201911071D0 GB 201911071 D0 GB201911071 D0 GB 201911071D0 GB 201911071 A GB201911071 A GB 201911071A GB 201911071 D0 GB201911071 D0 GB 201911071D0
Authority
GB
United Kingdom
Prior art keywords
xylitol
antibacterial activity
dermatological treatment
prebiotic oligosaccharides
selected prebiotic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1911071.7A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Meda Pharma SpA
Original Assignee
Meda Pharma SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meda Pharma SpA filed Critical Meda Pharma SpA
Priority to GBGB1911071.7A priority Critical patent/GB201911071D0/en
Publication of GB201911071D0 publication Critical patent/GB201911071D0/en
Priority to PCT/EP2020/071769 priority patent/WO2021023695A1/en
Priority to CN202080055687.2A priority patent/CN114206305A/en
Priority to EP20750268.3A priority patent/EP4007569A1/en
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716Glucans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716Glucans
    • A61K31/721Dextrans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/733Fructosans, e.g. inulin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • A61K8/345Alcohols containing more than one hydroxy group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02Local antiseptics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005Antimicrobial preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/005Preparations for sensitive skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/007Preparations for dry skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Birds (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Emergency Medicine (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB1911071.7A 2019-08-02 2019-08-02 Antibacterial activity of selected prebiotic oligosaccharides and xylitol in dermatological treatment Ceased GB201911071D0 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
GBGB1911071.7A GB201911071D0 (en) 2019-08-02 2019-08-02 Antibacterial activity of selected prebiotic oligosaccharides and xylitol in dermatological treatment
PCT/EP2020/071769 WO2021023695A1 (en) 2019-08-02 2020-08-03 Combinations of oligosaccharides and xylitol for dermatological treatment
CN202080055687.2A CN114206305A (en) 2019-08-02 2020-08-03 Combination of oligosaccharides and xylitol for skin treatment
EP20750268.3A EP4007569A1 (en) 2019-08-02 2020-08-03 Combinations of oligosaccharides and xylitol for dermatological treatment

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1911071.7A GB201911071D0 (en) 2019-08-02 2019-08-02 Antibacterial activity of selected prebiotic oligosaccharides and xylitol in dermatological treatment

Publications (1)

Publication Number Publication Date
GB201911071D0 true GB201911071D0 (en) 2019-09-18

Family

ID=67990765

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1911071.7A Ceased GB201911071D0 (en) 2019-08-02 2019-08-02 Antibacterial activity of selected prebiotic oligosaccharides and xylitol in dermatological treatment

Country Status (4)

Country Link
EP (1) EP4007569A1 (en)
CN (1) CN114206305A (en)
GB (1) GB201911071D0 (en)
WO (1) WO2021023695A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3129083B1 (en) * 2021-11-18 2024-09-27 Beghin Meiji COSMETIC METHOD AND COMPOSITION BASED ON SHORT-CHAIN FRUCTO-OLIGOSACCHARIDES
FR3118711A1 (en) * 2021-01-12 2022-07-15 Beghin Meiji COSMETIC METHOD AND COMPOSITION BASED ON SHORT CHAIN FRUCTO-OLIGOSACCHARIDES
JP2024502375A (en) * 2021-01-12 2024-01-18 ベギン,メイジ Cosmetic methods and compositions based on short-chain fructooligosaccharides and raw starches
JPWO2022230925A1 (en) * 2021-04-28 2022-11-03
WO2022245567A1 (en) 2021-05-20 2022-11-24 Smile Makers, Llc Oral hygiene compositions and methods of use

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003238381A (en) * 2002-02-13 2003-08-27 Fancl Corp Cosmetic composition
FR2863887B1 (en) * 2003-12-23 2008-05-16 Jean Noel Thorel PROCESS FOR INNOFORMING A BIOCOMPATIBLE GALENIC BASE
KR20130014766A (en) * 2011-08-01 2013-02-12 주식회사 함소아제약 Oriental medicine composition for curing rhinitis in children and manufacturing method thereof
CN103462881B (en) * 2013-10-10 2016-06-22 深圳市容大生物技术有限公司 A kind of composition and method of making the same promoting skin microecological balance
CN105325573A (en) * 2015-10-31 2016-02-17 安徽天祥粮油食品有限公司 Dessert crisp crust oil and preparation method thereof
FR3045385B1 (en) * 2015-12-22 2019-12-20 Jean-Noel Thorel COSMETIC COMPOSITION COMPRISING NERVE GROWTH FACTOR EXPRESSION INHIBITORS FOR THE TREATMENT OF PSORIASIS, ATOPIC DERMATITIS AND PRURITUS
EP4241855A3 (en) * 2017-06-27 2023-10-25 Rottapharm SPA Antibacterial activity of galactooligosaccharide and xylitol in dermatological treatments
CN108324654A (en) * 2018-04-25 2018-07-27 佛山娇芙生物科技有限公司 A kind of eye-care compositions containing gingko Asian puccoon root extract and its application
CN108355013A (en) * 2018-05-23 2018-08-03 佛山市芊茹化妆品有限公司 A kind of multi-functional dispel livid ring around eye composition and its application
CN110651944A (en) * 2019-11-06 2020-01-07 莫长根 Health-care solid beverage of green turtle and preparation method thereof

Also Published As

Publication number Publication date
EP4007569A1 (en) 2022-06-08
CN114206305A (en) 2022-03-18
WO2021023695A1 (en) 2021-02-11

Similar Documents

Publication Publication Date Title
GB201911071D0 (en) Antibacterial activity of selected prebiotic oligosaccharides and xylitol in dermatological treatment
EP3644945C0 (en) Antibacterial activity of galactooligosaccharide and xylitol in dermatological treatments
GB2563212B (en) Cleaning, healing and regeneration of tissue and wounds
RS60410B1 (en) Compositions for use in methods for the treatment of wounds, disorders, and diseases of the skin
IL255203B (en) Topical pharmaceutical emulsion compositions comprising 3,5-dihydroxy-4-isopropyl-trans-stilbene and use thereof in the treatment or prophylaxis of dermatological conditions or disorders
IL268327A (en) A pharmaceutical composition for use in the treatment or prevention of a c5-related disease and a method for treating or preventing a c5-related disease
IL285715A (en) Topical rapamycin formulations and their use in treating facial angiofibromas and other skin disorders
WO2016025635A3 (en) Combination therapy for treating cancer
EP3639833A4 (en) Agent for the prevention or treatment of fat-related diseases and/or inflammation
EP3753557A4 (en) PREVENTIVE OR THERAPEUTIC AGENT AND PHARMACEUTICAL COMPOSITION FOR INFLAMMATORY DISEASES OR BONE DISEASES
WO2016043874A3 (en) Combination therapy for treating cancer
MX2018000262A (en) Therapeutic uses of berberine formulations.
EP3915985A4 (en) Pyrrolopyridine derivative and use thereof in prevention and treatment of protein kinase-related disease
SG11202000423XA (en) Treatment of fabry disease in ert-naïve and ert-experienced patients
EP3590338A3 (en) Medical treatments based on anamorelin
EP3471562A4 (en) Synthetic compositions comprising human milk oligosaccharides for use the prevention and treatment of disorders
ZA201905309B (en) Pharmaceutical active ingredient and use thereof, in particular for the prevention and treatment of metabolic disorders in humans and animals
ZA201906964B (en) Prevention and/or treatment of inflammatory skin disease
GB2570180B (en) Structure strengthening hair treatment agent with increased care effect
TWI799923B (en) Use of thioimidazolidinone drugs in the treatment of covid-19 disease
BR112018007269A2 (en) oxa-diazaospiro compounds having activity against pain
PL3983066T3 (en) Treatment of heart failure and fibrosis in human subjects
HK40112175A (en) Treatment of fabry disease in ert-naive and ert-experienced patients
HK40110848A (en) Treatment of fabry disease in ert-naive and ert-experienced patients
HK40109071A (en) Treatment of fabry disease in ert-naive and ert-experienced patients

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)